Skip to main content
  • Saved

made a Post

No Benefit for Post-operative Radiotherapy in Non-small-cell Lung Cancer [ESMO2020 Press Release]

Source :

https://www.esmo.org/newsroom/press-office/esmo2020-nsclc-port-lungart-radiotherapy-lung-cancer

LUGANO, Switzerland - Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020. These results give the oncology community a long-awaited answer.